share_log

HUTCHMED (China) analyst ratings

Benzinga Analyst Ratings ·  Aug 9, 2022 08:54
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
08/09/2022 14.86% Goldman Sachs $14 → $16 Maintains Neutral
08/02/2022 0.5% Goldman Sachs $16 → $14 Maintains Neutral
09/22/2021 230.22% Goldman Sachs → $46 Downgrades Buy → Neutral
08/03/2021 273.3% Jefferies → $52 Initiates Coverage On → Buy
03/13/2020 Cantor Fitzgerald Initiates Coverage On → Overweight
02/20/2020 172.79% Goldman Sachs → $38 Initiates Coverage On → Buy
11/19/2019 CLSA Initiates Coverage On → Buy
10/23/2019 B of A Securities Reinstates → Buy
03/04/2019 Deutsche Bank Initiates Coverage On → Buy
10/17/2017 172.79% Canaccord Genuity $30 → $38 Maintains Buy

HUTCHMED (China) Questions & Answers

What is the target price for HUTCHMED (China) (HCM)?

The latest price target for HUTCHMED (China) (NASDAQ: HCM) was reported by Goldman Sachs on August 9, 2022. The analyst firm set a price target for $16.00 expecting HCM to rise to within 12 months (a possible 14.86% upside). 3 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for HUTCHMED (China) (HCM)?

The latest analyst rating for HUTCHMED (China) (NASDAQ: HCM) was provided by Goldman Sachs, and HUTCHMED (China) maintained their neutral rating.

When is the next analyst rating going to be posted or updated for HUTCHMED (China) (HCM)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of HUTCHMED (China), and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for HUTCHMED (China) was filed on August 9, 2022 so you should expect the next rating to be made available sometime around August 9, 2023.

Is the Analyst Rating HUTCHMED (China) (HCM) correct?

While ratings are subjective and will change, the latest HUTCHMED (China) (HCM) rating was a maintained with a price target of $14.00 to $16.00. The current price HUTCHMED (China) (HCM) is trading at is $13.93, which is out of the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment